Cargando…
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
SIMPLE SUMMARY: The risk of recurrence of patients with localized muscle-invasive bladder carcinoma (MIBC) is still high. The outcomes of surgery and perioperative therapy are limited, and several patients are not candidates for neoadjuvant chemotherapy and have no further alternatives available. In...
Autores principales: | Esteban-Villarrubia, Jorge, Torres-Jiménez, Javier, Bueno-Bravo, Carolina, García-Mondaray, Rebeca, Subiela, José Daniel, Gajate, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913718/ https://www.ncbi.nlm.nih.gov/pubmed/36765525 http://dx.doi.org/10.3390/cancers15030566 |
Ejemplares similares
-
Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
por: Gajate, Pablo, et al.
Publicado: (2020) -
Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives
por: Kim, In-Ho, et al.
Publicado: (2021) -
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023) -
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene
por: Torres-Jiménez, Javier, et al.
Publicado: (2022) -
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist
por: Torres-Jiménez, Javier, et al.
Publicado: (2021)